Preclinical evaluation of the tyrosine kinase inhibitor SU11248 as a single agent and in combination with "standard of care" therapeutic agents for the treatment of breast cancer
(Q40623012)
scientific article published on October 1, 2003
scientific article published on October 1, 2003
Language: